PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ADMA vs. VRT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ADMA and VRT is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

ADMA vs. VRT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and Vertiv Holdings Co. (VRT). The values are adjusted to include any dividend payments, if applicable.

200.00%400.00%600.00%800.00%1,000.00%1,200.00%1,400.00%NovemberDecember2025FebruaryMarchApril
239.33%
646.13%
ADMA
VRT

Key characteristics

Sharpe Ratio

ADMA:

3.56

VRT:

-0.15

Sortino Ratio

ADMA:

4.20

VRT:

0.29

Omega Ratio

ADMA:

1.56

VRT:

1.04

Calmar Ratio

ADMA:

4.76

VRT:

-0.18

Martin Ratio

ADMA:

16.40

VRT:

-0.45

Ulcer Index

ADMA:

15.00%

VRT:

24.29%

Daily Std Dev

ADMA:

69.05%

VRT:

72.96%

Max Drawdown

ADMA:

-91.28%

VRT:

-71.24%

Current Drawdown

ADMA:

-5.79%

VRT:

-52.28%

Fundamentals

Market Cap

ADMA:

$5.08B

VRT:

$27.88B

EPS

ADMA:

$0.81

VRT:

$1.28

PE Ratio

ADMA:

26.31

VRT:

57.20

PEG Ratio

ADMA:

0.00

VRT:

0.65

PS Ratio

ADMA:

11.92

VRT:

3.48

PB Ratio

ADMA:

14.57

VRT:

11.45

Total Revenue (TTM)

ADMA:

$344.58M

VRT:

$6.37B

Gross Profit (TTM)

ADMA:

$180.30M

VRT:

$2.37B

EBITDA (TTM)

ADMA:

$123.41M

VRT:

$1.10B

Returns By Period

In the year-to-date period, ADMA achieves a 24.26% return, which is significantly higher than VRT's -35.53% return.


ADMA

YTD

24.26%

1M

3.40%

6M

35.04%

1Y

243.71%

5Y*

51.42%

10Y*

9.01%

VRT

YTD

-35.53%

1M

-17.90%

6M

-34.73%

1Y

-9.51%

5Y*

48.34%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ADMA vs. VRT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA
The Risk-Adjusted Performance Rank of ADMA is 9898
Overall Rank
The Sharpe Ratio Rank of ADMA is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of ADMA is 9898
Sortino Ratio Rank
The Omega Ratio Rank of ADMA is 9797
Omega Ratio Rank
The Calmar Ratio Rank of ADMA is 9999
Calmar Ratio Rank
The Martin Ratio Rank of ADMA is 9898
Martin Ratio Rank

VRT
The Risk-Adjusted Performance Rank of VRT is 4646
Overall Rank
The Sharpe Ratio Rank of VRT is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of VRT is 4848
Sortino Ratio Rank
The Omega Ratio Rank of VRT is 4848
Omega Ratio Rank
The Calmar Ratio Rank of VRT is 4343
Calmar Ratio Rank
The Martin Ratio Rank of VRT is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ADMA vs. VRT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Vertiv Holdings Co. (VRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ADMA, currently valued at 3.56, compared to the broader market-2.00-1.000.001.002.003.00
ADMA: 3.56
VRT: -0.15
The chart of Sortino ratio for ADMA, currently valued at 4.20, compared to the broader market-6.00-4.00-2.000.002.004.00
ADMA: 4.20
VRT: 0.29
The chart of Omega ratio for ADMA, currently valued at 1.56, compared to the broader market0.501.001.502.00
ADMA: 1.56
VRT: 1.04
The chart of Calmar ratio for ADMA, currently valued at 7.75, compared to the broader market0.001.002.003.004.00
ADMA: 7.75
VRT: -0.18
The chart of Martin ratio for ADMA, currently valued at 16.40, compared to the broader market-5.000.005.0010.0015.0020.00
ADMA: 16.40
VRT: -0.45

The current ADMA Sharpe Ratio is 3.56, which is higher than the VRT Sharpe Ratio of -0.15. The chart below compares the historical Sharpe Ratios of ADMA and VRT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.008.00NovemberDecember2025FebruaryMarchApril
3.56
-0.15
ADMA
VRT

Dividends

ADMA vs. VRT - Dividend Comparison

ADMA has not paid dividends to shareholders, while VRT's dividend yield for the trailing twelve months is around 0.17%.


TTM20242023202220212020
ADMA
ADMA Biologics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
VRT
Vertiv Holdings Co.
0.17%0.10%0.05%0.07%0.04%0.05%

Drawdowns

ADMA vs. VRT - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, which is greater than VRT's maximum drawdown of -71.24%. Use the drawdown chart below to compare losses from any high point for ADMA and VRT. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-5.79%
-52.28%
ADMA
VRT

Volatility

ADMA vs. VRT - Volatility Comparison

The current volatility for ADMA Biologics, Inc. (ADMA) is 19.50%, while Vertiv Holdings Co. (VRT) has a volatility of 31.06%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than VRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%NovemberDecember2025FebruaryMarchApril
19.50%
31.06%
ADMA
VRT

Financials

ADMA vs. VRT - Financials Comparison

This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Vertiv Holdings Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab